Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sensus Healthcare (SRTS) Other financing activities (2017 - 2025)

Historic Other financing activities for Sensus Healthcare (SRTS) over the last 9 years, with Q3 2025 value amounting to $73000.0.

  • Sensus Healthcare's Other financing activities rose 6222.22% to $73000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $346000.0, marking a year-over-year increase of 2958.8%. This contributed to the annual value of $325000.0 for FY2024, which is 947.08% down from last year.
  • Sensus Healthcare's Other financing activities amounted to $73000.0 in Q3 2025, which was up 6222.22% from $72000.0 recorded in Q2 2025.
  • Sensus Healthcare's Other financing activities' 5-year high stood at $206000.0 during Q3 2021, with a 5-year trough of $40000.0 in Q2 2022.
  • Over the past 5 years, Sensus Healthcare's median Other financing activities value was $69500.0 (recorded in 2023), while the average stood at $87611.1.
  • Over the last 5 years, Sensus Healthcare's Other financing activities had its largest YoY gain of 45675.68% in 2021, and its largest YoY loss of 6129.03% in 2021.
  • Sensus Healthcare's Other financing activities (Quarter) stood at $90000.0 in 2021, then soared by 74.44% to $157000.0 in 2022, then plummeted by 59.24% to $64000.0 in 2023, then soared by 90.62% to $122000.0 in 2024, then tumbled by 40.16% to $73000.0 in 2025.
  • Its Other financing activities was $73000.0 in Q3 2025, compared to $72000.0 in Q2 2025 and $79000.0 in Q1 2025.